FDA approves St. Jude Medical’s stroke prevention device

Saint Paul, Minn.-based St. Jude Medical earned Food and Drug Administration approval for the Amplatzer PFO Occluder.

Advertisement

The device, used to lower the risk of stroke, is intended for patients who already had one stroke caused by a blood clot passing through a hole in the heart and into the brain.

The device prevents a second stroke from occurring by closing up the hole in the patient’s heart. Clinicians insert the Amplatzer PFO Occluder through a catheter in a patient’s leg and into the patient’s heart.

More articles on supply chain:

FedEx subsidiary offers multi-tenant warehousing solution
5 latest FDA approvals
EpiPen price hikes cost DOD millions

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.